Context Therapeutics Inc.
CNTX$2.03▼ 1.22% 24h
Context Therapeutics Inc.CNTX$2.03
-$0.1046(-4.91%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
$186.06M
P/E ratio
—
EPS (diluted)
$-0.38
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
—
Net income
$-36.12M
Net margin
—
Gross margin
—
Dividends & financials
Context Therapeutics Inc. (CNTX) reported revenue of — and net income of $-36.12M, or $-0.38 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.